Systemic Lupus Erythematosus Drug Market Insights Video

According to Cognitive Market Research, the global Systemic lupus erythematosus drugmarket size is USD 191581.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 5.50% from 2024 to 2031.

• North America held the major market share of more than 40% of the global revenue with a market size of USD 76632.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.
• Europe accounted for a share of over 30% of the global revenue with a market size of USD 57474.36 million.
• Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 44063.68 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.
• Latin America market share of more than 5% of the global revenue with a market size of USD 9579.06 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.
• Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 3831.62 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
• The oral medications emerge as the dominant route of administration. Oral administration offers several advantages, including convenience, ease of use, and improved patient compliance.